• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏影像报告和数据系统(LI-RADS):从其起源到最近纳入美国肝病研究学会(AASLD)临床实践指南的概念与历史回顾

LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.

作者信息

Elsayes Khaled M, Kielar Ania Z, Chernyak Victoria, Morshid Ali, Furlan Alessandro, Masch William R, Marks Robert M, Kamaya Aya, Do Richard K G, Kono Yuko, Fowler Kathryn J, Tang An, Bashir Mustafa R, Hecht Elizabeth M, Jambhekar Kedar, Lyshchik Andrej, Rodgers Shuchi K, Heiken Jay P, Kohli Marc, Fetzer David T, Wilson Stephanie R, Kassam Zahra, Mendiratta-Lala Mishal, Singal Amit G, Lim Christopher S, Cruite Irene, Lee James, Ash Ryan, Mitchell Donald G, McInnes Matthew D F, Sirlin Claude B

机构信息

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA,

Department of Radiology, University of Toronto, ON, Canada.

出版信息

J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019.

DOI:10.2147/JHC.S186239
PMID:30788336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6368120/
Abstract

The Liver Imaging Reporting and Data System (LI-RADS) is a comprehensive system for standardizing the terminology, technique, interpretation, reporting, and data collection of liver observations in individuals at high risk for hepatocellular carcinoma (HCC). LI-RADS is supported and endorsed by the American College of Radiology (ACR). Upon its initial release in 2011, LI-RADS applied only to liver observations identified at CT or MRI. It has since been refined and expanded over multiple updates to now also address ultrasound-based surveillance, contrast-enhanced ultrasound for HCC diagnosis, and CT/MRI for assessing treatment response after locoregional therapy. The LI-RADS 2018 version was integrated into the HCC diagnosis, staging, and management practice guidance of the American Association for the Study of Liver Diseases (AASLD). This article reviews the major LI-RADS updates since its 2011 inception and provides an overview of the currently published LI-RADS algorithms.

摘要

肝脏影像报告和数据系统(LI-RADS)是一个全面的系统,用于规范肝细胞癌(HCC)高危个体肝脏观察的术语、技术、解读、报告和数据收集。LI-RADS得到了美国放射学会(ACR)的支持和认可。2011年首次发布时,LI-RADS仅适用于CT或MRI检查发现的肝脏观察结果。此后,经过多次更新,它不断完善和扩展,如今还涵盖基于超声的监测、用于HCC诊断的超声造影以及用于评估局部区域治疗后治疗反应的CT/MRI。2018版LI-RADS已纳入美国肝病研究协会(AASLD)的HCC诊断、分期和管理实践指南。本文回顾了LI-RADS自2011年创立以来的主要更新内容,并概述了目前已发布的LI-RADS算法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/90a8f47d0137/jhc-6-049Fig20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/73343688813c/jhc-6-049Fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/4df91ce3a161/jhc-6-049Fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/3fc2583079a2/jhc-6-049Fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/1ac5faa0c11b/jhc-6-049Fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/f86cb095c0a2/jhc-6-049Fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/8269b83beade/jhc-6-049Fig19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/90a8f47d0137/jhc-6-049Fig20.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/73343688813c/jhc-6-049Fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/4df91ce3a161/jhc-6-049Fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/3fc2583079a2/jhc-6-049Fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/1ac5faa0c11b/jhc-6-049Fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/f86cb095c0a2/jhc-6-049Fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/8269b83beade/jhc-6-049Fig19.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0cbf/6368120/90a8f47d0137/jhc-6-049Fig20.jpg

相似文献

1
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance.肝脏影像报告和数据系统(LI-RADS):从其起源到最近纳入美国肝病研究学会(AASLD)临床实践指南的概念与历史回顾
J Hepatocell Carcinoma. 2019 Feb 5;6:49-69. doi: 10.2147/JHC.S186239. eCollection 2019.
2
White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.美国腹部放射学会肝癌诊断疾病聚焦专家组关于 CT 和 MRI 的 LI-RADS v2018 白皮书。
Abdom Radiol (NY). 2018 Oct;43(10):2625-2642. doi: 10.1007/s00261-018-1744-4.
3
LI-RADS: Past, Present, and Future, From the Special Series on Radiology Reporting and Data Systems.LI-RADS:过去、现在和未来,来自放射学报告和数据系统特刊。
AJR Am J Roentgenol. 2021 Feb;216(2):295-304. doi: 10.2214/AJR.20.24272. Epub 2020 Dec 23.
4
Diagnosis of Non-Hepatocellular Carcinoma Malignancies in Patients With Risks for Hepatocellular Carcinoma: CEUS LI-RADS Versus CT/MRI LI-RADS.肝细胞癌风险患者中非肝细胞癌恶性肿瘤的诊断:对比增强超声LI-RADS与CT/MRI LI-RADS
Front Oncol. 2021 Apr 12;11:641195. doi: 10.3389/fonc.2021.641195. eCollection 2021.
5
Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.超声造影对肝细胞癌鉴别诊断的诊断准确性:爱克发与CEUS-LI-RADS对比
Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.
6
Introduction to the Liver Imaging Reporting and Data System for Hepatocellular Carcinoma.肝脏成像报告和数据系统在肝细胞癌中的应用简介。
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1228-1238. doi: 10.1016/j.cgh.2018.10.014. Epub 2018 Oct 13.
7
Compared with CT/MRI LI-RADS, whether CEUS LI-RADS is worth popularizing in diagnosis of hepatocellular carcinoma?-a direct head-to-head meta-analysis.与CT/MRI肝脏影像报告和数据系统(LI-RADS)相比,对比增强超声(CEUS)肝脏影像报告和数据系统在肝细胞癌诊断中是否值得推广?——一项直接的头对头荟萃分析。
Quant Imaging Med Surg. 2023 Aug 1;13(8):4919-4932. doi: 10.21037/qims-22-1383. Epub 2023 May 24.
8
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
9
Imaging diagnosis of hepatocellular carcinoma: LI-RADS.肝癌的影像学诊断:LI-RADS。
Chin Clin Oncol. 2021 Feb;10(1):3. doi: 10.21037/cco-20-107. Epub 2020 Jun 9.
10
Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.比较 AASLD 和 LI-RADS 标准在诊断小于 3cm 的 HCC 方面的准确性。
J Hepatol. 2018 Apr;68(4):715-723. doi: 10.1016/j.jhep.2017.12.014. Epub 2017 Dec 21.

引用本文的文献

1
Preoperative Prediction of a Rare and Highly Aggressive Subtype of Hepatocellular Carcinoma Based on Multimodal Imaging and Clinical Indicators.基于多模态成像和临床指标对一种罕见且侵袭性强的肝细胞癌亚型进行术前预测
J Hepatocell Carcinoma. 2025 Jun 30;12:1253-1266. doi: 10.2147/JHC.S533963. eCollection 2025.
2
Current State of Evidence for Use of MRI in LI-RADS.肝脏影像报告和数据系统(LI-RADS)中使用MRI的证据现状
J Magn Reson Imaging. 2025 Sep;62(3):640-653. doi: 10.1002/jmri.29748. Epub 2025 Feb 21.
3
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

本文引用的文献

1
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理:美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
2
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.肝硬化患者肝细胞癌早期检测的监测成像和甲胎蛋白:一项荟萃分析。
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
3
LI-RADS: a glimpse into the future.
CT/MRI LI-RADS 2024 更新:治疗反应评估。
Radiology. 2024 Nov;313(2):e232408. doi: 10.1148/radiol.232408.
4
Imaging of cystic fibrosis manifestations in the abdomen.腹部囊性纤维化表现的影像学检查
Abdom Radiol (NY). 2025 May;50(5):1953-1978. doi: 10.1007/s00261-024-04636-7. Epub 2024 Nov 11.
5
National Liver Cancer Screening Trial (TRACER) study protocol.国家肝癌筛查试验(TRACER)研究方案。
Hepatol Commun. 2024 Nov 4;8(11). doi: 10.1097/HC9.0000000000000565. eCollection 2024 Nov 1.
6
Lessons learned: strategies for implementing and the ongoing use of LI-RADS in your practice.经验教训:在实践中实施和持续使用肝脏影像报告和数据系统(LI-RADS)的策略。
Abdom Radiol (NY). 2025 May;50(5):2053-2065. doi: 10.1007/s00261-024-04643-8. Epub 2024 Oct 23.
7
CT/MRI technical pitfalls for diagnosis and treatment response assessment using LI-RADS and how to optimize.使用LI-RADS进行诊断和治疗反应评估时CT/MRI的技术陷阱及优化方法
Abdom Radiol (NY). 2025 May;50(5):2022-2037. doi: 10.1007/s00261-024-04632-x. Epub 2024 Oct 22.
8
Survival Outcomes Among Patients With Hepatocellular Carcinoma in a Large Integrated US Health System.大型综合性美国医疗体系中肝细胞癌患者的生存结局。
JAMA Netw Open. 2024 Sep 3;7(9):e2435066. doi: 10.1001/jamanetworkopen.2024.35066.
9
Is there added value of the hepatobiliary phase of MRI with hepatobiliary contrast agents for hepatocellular carcinoma diagnosis? A meta-analysis.使用肝胆造影剂的MRI肝胆期对肝细胞癌诊断是否具有附加价值?一项荟萃分析。
Pol J Radiol. 2024 Aug 19;89:e402-e413. doi: 10.5114/pjr/189614. eCollection 2024.
10
Tumor diameter and enhancing capsule, as well as previous interventional treatments, as potential predictors of vascular lake phenomenon in hepatocellular carcinoma patients treated with drug-eluting beads transarterial chemoembolization.肿瘤直径、强化包膜以及既往介入治疗,作为接受载药微球经动脉化疗栓塞术治疗的肝细胞癌患者出现血管湖现象的潜在预测因素。
J Clin Imaging Sci. 2024 Aug 10;14:29. doi: 10.25259/JCIS_66_2024. eCollection 2024.
LI-RADS:未来一瞥。
Abdom Radiol (NY). 2018 Jan;43(1):231-236. doi: 10.1007/s00261-017-1448-1.
4
2017 Version of LI-RADS for CT and MR Imaging: An Update.2017 版 CT 和 MR 成像肝脏影像学报告和数据系统:更新。
Radiographics. 2017 Nov-Dec;37(7):1994-2017. doi: 10.1148/rg.2017170098.
5
Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.LI-RADS 版本 2014 算法和影像学特征在诊断肝细胞癌中的读者间可靠性:一项大型国际多读者研究。
Radiology. 2018 Jan;286(1):173-185. doi: 10.1148/radiol.2017170376. Epub 2017 Nov 1.
6
LI-RADS categories: concepts, definitions, and criteria.LI-RADS 类别:概念、定义和标准。
Abdom Radiol (NY). 2018 Jan;43(1):101-110. doi: 10.1007/s00261-017-1334-x.
7
CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI.CEUS LI-RADS:算法、实施及与 CT/MRI 的主要差异。
Abdom Radiol (NY). 2018 Jan;43(1):127-142. doi: 10.1007/s00261-017-1250-0.
8
Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.局部区域治疗肝癌和新的 LI-RADS 治疗反应算法。
Abdom Radiol (NY). 2018 Jan;43(1):218-230. doi: 10.1007/s00261-017-1281-6.
9
LI-RADS algorithm: CT and MRI.LI-RADS 算法:CT 和 MRI。
Abdom Radiol (NY). 2018 Jan;43(1):111-126. doi: 10.1007/s00261-017-1228-y.
10
LI-RADS ancillary features on CT and MRI.LI-RADS 在 CT 和 MRI 上的辅助特征。
Abdom Radiol (NY). 2018 Jan;43(1):82-100. doi: 10.1007/s00261-017-1220-6.